1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
214.13%
Revenue growth above 1.5x 6247.T's 10.47%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
67.11%
Gross profit growth above 1.5x 6247.T's 5.61%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
65.51%
EBIT growth above 1.5x 6247.T's 18.51%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
62.95%
Operating income growth above 1.5x 6247.T's 15.07%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
43.67%
Net income growth above 1.5x 6247.T's 25.50%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
43.69%
EPS growth above 1.5x 6247.T's 25.35%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
43.69%
Diluted EPS growth above 1.5x 6247.T's 25.35%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.00%
Share change of 0.00% while 6247.T is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.00%
Diluted share change of 0.00% while 6247.T is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
128.75%
OCF growth 1.25-1.5x 6247.T's 90.41%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
128.75%
FCF growth 1.25-1.5x 6247.T's 90.41%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-89.90%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-89.90%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-89.90%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
94.93%
Below 50% of 6247.T's 193.92%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
94.93%
Below 50% of 6247.T's 193.92%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
94.93%
Below 50% of 6247.T's 193.92%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.20%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
4.29%
Asset growth above 1.5x 6247.T's 2.75%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-10.32%
We have a declining book value while 6247.T shows 0.34%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-2.55%
We’re deleveraging while 6247.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.